10/4/2022
Phase 2 Clinical Trial for Celiac Disease
The PROACTIVE Celiac Study is a phase 2 clinical trial testing the safety and effects of the investigational medication PRV-015.
Continue ReadingResearch News
9/19/2022
New Potential Treatment for Celiac Disease in Clinical Study
Consider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.
Continue Reading7/6/2022
Strong Link Found Between Celiac Disease and Inflammatory Bowel Disease
New research studying the association of celiac disease and inflammatory bowel disease (IBD) shows a strong relationship between the two conditions.
Continue Reading7/1/2022
Celiac Disease Foundation CEO, Marilyn G. Geller, to Present at SSCD Webinar on July 27
On July 27, Celiac Disease Foundation CEO, Marilyn G. Geller, will be presenting the “Role of Patient Advocacy in Clinical Trials” on a webinar hosted by the Society for the Study of Celiac Disease.
Continue Reading6/21/2022
9 Meters Discontinues Phase 3 Clinical Trial for Potential Celiac Disease Drug Larazotide
An analysis by an independent statistician of the ongoing Phase 3 trial for Larazotide has concluded that a substantial number of new patients would have to be added to the existing trial in order to get scientifically meaningful results.
Continue ReadingRecent Posts
- CDF Announces Recipients of Inaugural Celiac Disease Research Prizes
- Anokion Announces KAN-101 Phase 1 Success & Phase 2 Plans
- CDF Awards Research Grant to UC Davis to Reduce Wheat Allergenicity- November 2021 Marilyn's Message
- Impact of My PCORI Panel Appointment - Marilyn's Message October 2021
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Research News
- Research Press
- Trending Topics
Marilyn's Message
8/30/2022
Read moreMake Your Voice Heard – Marilyn’s Message August 2022
